학술논문
1119PD - Inducible T cell costimulatory (ICOS) receptor agonist, GSK3359609 (GSK609) alone and in combination with pembrolizumab (pembro): Preliminary results from INDUCE-1 expansion cohorts (EC) in head and neck squamous cell carcinoma (HNSCC)
Document Type
Abstract
Author
Source
In Annals of Oncology October 2019 30 Supplement 5:v454-v455
Subject
Language
ISSN
0923-7534